Flawless Beauty Ling Zhi Capsules Recall: Unapproved Drug Risk
Flawless Beauty LLC recalls all Ling Zhi capsules sold individually or in kits due to being marketed without FDA approval. This unapproved drug poses health risks and requires immediate attention.
Recall notice
Marketed Without An Approved NDA/ANDA: Flawless Beauty, LLC is voluntarily recalling all lots of different products sold individually or as part of multi-unit kits in accordance with Consent Decree of Permanent Injunction ordered by the United States District Court due to misbranding and unapproved new drugs pursuant to the FD&C Act.
Contact the company
What happened, in plain English
Flawless Beauty LLC is recalling all Ling Zhi capsules sold individually or in multi-unit kits because they were marketed without FDA approval. This makes them unapproved drugs that could pose health risks. Read more at govinfonow.com/recall/40914-flawless-beauty-ling-zhi-capsules-recall-unapproved-drug-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/40914-flawless-beauty-ling-zhi-capsules-recall-unapproved-drug-risk · Updated October 7, 2026 · FDA enforcement record: FDA #D-0333-2018
Cite this page
“Flawless Beauty Ling Zhi Capsules Recall: Unapproved Drug Risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40914-flawless-beauty-ling-zhi-capsules-recall-unapproved-drug-risk. Based on FDA recall #D-0333-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0333-2018%22&limit=1).
Why it’s dangerous
These capsules were marketed without FDA approval, meaning they are unapproved drugs. The FDA requires drugs to be approved before being sold to ensure safety and effectiveness. Unapproved drugs can cause health risks.
Who’s affected
Anyone who owns or uses Ling Zhi capsules from Flawless Beauty LLC. People who have taken these capsules without FDA approval may be at risk.
How to tell if you have this one
Check for Ling Zhi capsules sold by Flawless Beauty LLC. All lots are affected, so any individual or multi-unit kits are included.
- Brand
Flawless Beauty- Category
Drug
All 12 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Product was distributed U.S.A. nationwide.
| Recall number | Product, codes & lots |
|---|---|
| D-0324-2018 | Relumins Advanced Glutathione kits, 900 mg vials, 1500 mg vials and 3000 mg vials; all lots |
| D-0325-2018 | Relumins Vitamin C Solvent ampules; all lots |
| D-0326-2018 | Tatiomax Gluatathione Whitening kits, 1400mg vials, Made in Japan; all lots |
| D-0327-2018 | Laroscorbine Platinum Vitamin C 1 gm Collagen 0.35 gm, Roche; all lots |
| D-0328-2018 | Tationil Glutathione, 600 mg/ 4 mL, polvere e solvente per soluzione iniettabile, Teofarma, s.r.l.; all lots |
| D-0329-2018 | Laennec INJ, Placenta extract (human), 2mL vials, Manufactured by: GCJBP Corp, Korea; all lots |
| D-0330-2018 | Reiki Glutathione Whitening kits; all lots |
| D-0331-2018 | TP Drug Laboratories Vitamin C ampules; all lots |
| D-0332-2018 | Sterilized water for injections BP, 50 x 5 mL plastic ampules, Manufactured in India; all lots |
| D-0333-2018 | Ling Zhi capsules; all lots |
| D-0334-2018 | Saluta Glutathione Whitening kits, packaged in 600 mg, 1200 mg and 1800 mg glass vials, Manufactured by: Shandong Luye Pharmaceutical Co, Ltd, Yantai, Shandong. PRC; all lots |
| D-0335-2018 | TAD Glutathione Whitening Kits lyophilized powder for injection, 600 mg vials, 10 vials + 10 amps x 4 mL, Manufactured by: Biomedica Foscama Industria, Ferentino, Italy; all lots |
What to do — step by step
Check Product Details
Look for Ling Zhi capsules sold by Flawless Beauty LLC in any lot.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Product was distributed U.S.A. nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0333-2018 (January 19, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0333-2018 to see it in context.
- Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.